本文へスキップ

相互作用

Anti-inhibitor coagulant complex + Tranexamic acid

重症度: 重大

Anti-inhibitor coagulant complex and Tranexamic acid: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Tranexamic acid blocks fibrinolysis while anti-inhibitor coagulant complex (activated prothrombin complex concentrate) promotes clot formation. Together they raise the risk of thrombotic events, including venous thrombosis and myocardial infarction.

この相互作用をわかりやすく説明すると

Anti-inhibitor coagulant complex and Tranexamic acid can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

エビデンスレベル: Moderate

なぜ起こるのか

Additive prothrombotic effect from antifibrinolytic action combined with a procoagulant product.

対処法

Avoid concurrent use, or give tranexamic acid no sooner than about 6 to 12 hours after the complex per labeling. Monitor for signs of thrombosis.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、Anti-inhibitor coagulant complexとTranexamic acidの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Anti-inhibitor coagulant complex with Tranexamic acid?

MediHelp rates the interaction as major. Anti-inhibitor coagulant complex and Tranexamic acid can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tranexamic acid blocks fibrinolysis while anti-inhibitor coagulant complex (activated prothrombin complex concentrate) promotes clot formation. Together they raise the risk of thrombotic events, including venous thrombosis and myocardial infarction.

How serious is the interaction between Anti-inhibitor coagulant complex and Tranexamic acid?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use, or give tranexamic acid no sooner than about 6 to 12 hours after the complex per labeling. Monitor for signs of thrombosis.

What other medicines interact with Tranexamic acid?

MediHelp also lists interactions of Tranexamic acid with, for example, Dienogest / estradiol valerate, Ethinyl estradiol-drospirenone, Ethinyl estradiol-levonorgestrel. The full list is on the Tranexamic acid page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン